Our Leadership
Our Leadership
Our industry-leading team is dedicated to innovation and advancing the discovery, development, and commercialization of plant-based prescription medicines to address urgent global health needs.
Executive Management Team
Lisa Conte
Founder, President, and Chief Executive Officer
Massimo Radaelli, PhD
President of Jaguar International
Pravin Chaturvedi, PhD
Chief Scientific Officer and Chair of Scientific Advisory Board
Carol Lizak, MBA
Chief Financial Officer
Steve King, PhD
Chief Sustainable Supply,
Ethnobotanical Research, and IP Officer
Darlene Horton, MD
Chief Medical Officer
David Sesin, PhD
Chief Manufacturing Officer
Jonathan Wolin, JD, MBA
Chief of Staff, Chief Compliance Officer,
and General Counsel
Ian H. Wendt, MBA
Chief Commercial Officer
Karen Brunke, PhD
Executive Vice President, Corporate & Business Development
Susan Krizancic
National Sales Director at Jaguar family company Napo Pharmaceuticals
Board of Directors
Lisa Conte
Founder, President, and Chief Executive Officer
James Bochnowski
Chairman
John Micek III
Director
Jonathan B. Siegel
Director
Dr. Anula Jayasuriya
Director